uvstocks.io

Today’s CSR movers

CSX 4.0 ▲ 1.2

C 4.0 ▲ 1.2

EIX 3.1 ▲ 0.8

NWS 4.5 ▲ 0.8

NTAP 3.6 ▲ 0.5

PNR 3.6 ▲ 0.4

VRT 4.8 ▲ 0.4

MSI 4.4 ▼ 0.4

SWK 3.2 ▼ 0.4

SO 2.3 ▼ 0.8

Health Care · NYSE NYSE · WST

West Pharmaceutical Services

$352.13 -$193.67 -55.00% CLOSE 08.10.26

Convergence score

4.9 / 5.0 STRONG BULLISH

+0.1 vs last report

Overall valuation

Overvalued

Aggregated across multiple horizons

Consensus target (12mo)

$386.40 +9.7%

Range $295.00 — $447.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 08.10.26

UV Convergence Score

REPORT 08.10.26

4.9

/ 5.0

STRONG BULLISH

Consensus signal A

5.0

Consensus signal B

5.0

Consensus signal D

5.0

Rating trend signal

4.8

Multi-signal aggregate How CSR works →

Day Range

—

52W Range

—

Volume

—

Avg Vol

—

Mkt Cap

$24.92B

P/E

45.02

EPS (TTM)

$7.82

Div Yield

0.25%

Beta

0.88

Today's convergence

Convergence score sits at 4.9 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Overvalued

CSR direction

STRONG BULLISH

Last close

$352.13

Sector

Health Care

Valuation

Three horizons

UPDATED 08.10.26

Short term

0–3 MO

No target Strong Buy

Medium term

3–12 MO

$368+4.5% Buy

Long term

12–36 MO

$165.49-53.0% Overvalued

Open valuation →

Analysts

Coverage & consensus

5 PANELS

Mean target (12mo)

$386.40 +9.7%

RANGE $295.00 — $447.00

Analyst consensus

Consensus rating Buy

Blended score 4.4 / 5

Analysts tracked 86

Open analysts →

Financials

Key metrics

LATEST

P/E

45.02

EPS (TTM)

$7.82

Mkt Cap

$24.92B

Div Yield

0.25%

Beta

0.88

52W Range

—

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 08.10.26

Short term

0–3 MO

Strong Buy

Consensus target

No target available

Current analyst consensus rating from Barchart.

Medium term

3–12 MO

Buy

Consensus target

$368 +4.5%

RANGE $295 – $447

$295NOW $352.13$447

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Overvalued

Consensus target

$165.49 -53.0%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 45.02	PEG Ratio: -	DE Ratio: -
Free Cash Flow: -	PB Ratio: -	PS Ratio: -	Dividend: $0.22

Analyst coverage

Blended analyst consensus & targets.

5 PANELS · UPDATED 08.10.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.4 5 86

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $295.00 $386.40 — $447.00 +9.7%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 2 11 2 — —

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current Strong Buy 4.82 17

1 Mo Ago Strong Buy 4.81 16

2 Mo Ago Strong Buy 4.69 16

3 Mo Ago Strong Buy 4.44 16

Most recent analyst action LATEST DESK ACTION

Date

8/7/2026

Firm

Weiss Ratings

Action

Upgrade

Rating

Hold (C) ➝ Hold (C+)

Target

—

Full financial snapshot.

UPDATED 08.10.26

Quote snapshot 15 FIELDS

Prev Close

—

Open

—

Day Low

—

Day High

—

Bid

—

Ask

—

52W Low

—

52W High

—

50D Avg

342.46

200D Avg

287.32

Volume

—

Avg Vol

—

10D Avg Vol

—

52W Change

+46.12%

S&P 52W Change

—

Valuation ratios 10 FIELDS

P/E (TTM)

45.09

P/E (Fwd)

37.96

PEG (Fwd)

2.53

P/S

7.49

P/B

8.34

Book Value

42.47

EV/Revenue

7.45

EV/EBITDA

28.78

Mkt Cap

24.92B

Enterprise Val

24.80B

Profitability & returns 6 FIELDS

Profit Margin

16.98%

Gross Margin

36.79%

Operating Margin

21.97%

EBITDA Margin

25.90%

Return on Assets

11.38%

Return on Equity

19.09%

Growth 3 FIELDS

Revenue Growth (YoY)

—

Earnings Growth (YoY)

—

Earnings Growth (Q)

—

Balance sheet & cash flow 11 FIELDS

Total Revenue

3.33B

EBITDA

861.80M

Total Cash

—

Total Debt

316.50M

Cash / Share

—

Revenue / Share

—

Free Cash Flow

436.90M

Operating CF

662.20M

Debt / Equity

0.11

Current Ratio

2.82

Quick Ratio

1.82

Dividend 5 FIELDS

Fwd Dividend

$0.88

Dividend Yield

0.25%

Payout Ratio

11.27%

5Y Avg Yield

—

Ex-Div Date

Jul 29, 2026

Share statistics 7 FIELDS

Shares Out

70.38M

Float

63.27M

Shares Short

2.36M

% Short of Float

3.73%

Short Ratio

2.90

% Held Insiders

0.61%

% Held Institutions

97.36%

Calendar & events 5 FIELDS

Next Earnings

Jul 23, 2026

Fiscal Year End

—

Most Recent Qtr

—

Last Split

—

Split Date

—

Company 2 FIELDS

Industry

—

Employees

—